Literature DB >> 18822119

Transperitoneal laparoscopic adrenalectomy for metachronous contralateral adrenal metastasis from renal cell carcinoma: a case report.

Evangelos Zacharakis1, Maria J Ribal, Emmanouil Zacharakis, Hiten Rh Patel.   

Abstract

BACKGROUND: We report a case of metachronous solitary metastasis of renal cell carcinoma to the contralateral adrenal gland treated by laparoscopic transperitoneal adrenalectomy. CASE
PRESENTATION: A 58-year-old man presented to our institution for regular follow up, 2 years after a right radical nephrectomy with preservation of the ipsilateral adrenal gland, for a primary renal cell carcinoma. The patient remained asymptomatic but an abdominal computed tomography scan on follow up revealed a 6.5 x 4 cm2 mass in the left adrenal gland. A positron emission tomography scan was also performed to rule out other possible metastases, and a magnetic resonance imaging scan was used for accurate localization and determination of resectability of the adrenal tumour. A bone scan, metabolic screen, liver and renal function tests were all within normal limits. A laparoscopic transperitoneal adrenalectomy was then performed. The postoperative period was uneventful, and the patient was discharged on postoperative day two. The patient remains in satisfactory condition and no recurrence or adrenal insufficiency has been observed during 12 months follow up.
CONCLUSION: Metachronous contra lateral adrenal metastases from primary renal cell carcinoma are very rare but should always be suspected in any nephrectomised patient presenting with an adrenal tumour. Regular follow up in these patients accompanied with computed tomography imaging may help the surgeon to detect early lesions. Laparoscopic transperitoneal adrenalectomy is feasible, safe and effective, with minimal trauma to the patient.

Entities:  

Year:  2008        PMID: 18822119      PMCID: PMC2562357          DOI: 10.1186/1757-1626-1-185

Source DB:  PubMed          Journal:  Cases J        ISSN: 1757-1626


  12 in total

Review 1.  Laparoscopic adrenalectomy: new gold standard.

Authors:  C D Smith; C J Weber; J R Amerson
Journal:  World J Surg       Date:  1999-04       Impact factor: 3.352

Review 2.  Results of surgical treatment of kidney cancer with solitary metastasis to contralateral adrenal.

Authors:  J Plawner
Journal:  Urology       Date:  1991-03       Impact factor: 2.649

3.  Solitary metastasis from renal cell carcinoma.

Authors:  B M Tolia; W F Whitmore
Journal:  J Urol       Date:  1975-12       Impact factor: 7.450

Review 4.  Metachronous renal cell carcinoma metastasis to the contralateral adrenal gland.

Authors:  O J Kessler; E Mukamel; R Weinstein; E Gayer; M Konichezky; C Servadio
Journal:  Urology       Date:  1998-04       Impact factor: 2.649

5.  A case-controlled study of laparoscopic compared with open lateral adrenalectomy.

Authors:  T Imai; T Kikumori; M Ohiwa; T Mase; H Funahashi
Journal:  Am J Surg       Date:  1999-07       Impact factor: 2.565

6.  Laparoscopic adrenalectomy: experience with transabdominal and retroperitoneal approaches.

Authors:  C Chee; T Ravinthiran; C Cheng
Journal:  Urology       Date:  1998-01       Impact factor: 2.649

7.  Distant metastasis of renal adenocarcinoma in nephrectomized cases.

Authors:  H Saitoh; M Nakayama; K Nakamura; T Satoh
Journal:  J Urol       Date:  1982-06       Impact factor: 7.450

8.  Contralateral adrenal metastasis of renal cell carcinoma: treatment, outcome and a review.

Authors:  W K Lau; H Zincke; C M Lohse; J C Cheville; A L Weaver; M L Blute
Journal:  BJU Int       Date:  2003-06       Impact factor: 5.588

9.  Renal cell carcinoma: the Ochsner Medical Institution experience (1945-1978).

Authors:  H A Fuselier; S L Guice; W Brannan; M G Ochsner; K V Sangisetty; E N Beckman; C A Barnes
Journal:  J Urol       Date:  1983-09       Impact factor: 7.450

10.  Prospective analysis of the incidence of ipsilateral adrenal metastasis in localized renal cell carcinoma.

Authors:  B A Kletscher; J Qian; D G Bostwick; M L Blute; H Zincke
Journal:  J Urol       Date:  1996-06       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.